Hereditary syndromes in pediatric hematooncology
Hematooncological diseases head the list in the structure of malignant neoplasms of childhood. Somatic mutations in tumor clone cells have been well studied, included in modern classifications, and are used to stratify patients into prognostic risk groups and select a therapy program. At the same ti...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Union of pediatricians of Russia
2023-12-01
|
Series: | Педиатрическая фармакология |
Subjects: | |
Online Access: | https://www.pedpharma.ru/jour/article/view/2377 |